Just Released: ASGCT 2024 Cell & Gene Therapy Curriculum
ASGCT (American Society of Gene and Cell Therapy) and NORD (National Organization for Rare Disorders) have partnered exclusively with PlatformQ Health to produce accredited gene and cell therapy education with top specialist experts. Together, the companies are delivering continuing medical education for clinicians as well as educational programs for patients and their families. Click here to watch the program!
“This strategic partnership is crucial for helping providers and patients make the most of their understanding of emerging therapies,” said PlatformQ Health CEO Robert Rosenbloom. “It is extremely gratifying to partner with a deeply committed professional membership society such as the American Society of Gene & Cell Therapy to deliver education about life-altering new therapies.”
Poster Presentation: May 9th at ASGCT Annual Meeting
“Practical Considerations with Gene-Transfer Therapy for Patients with DMD” has been selected for poster presentation at the 2024 ASGCT 27th Annual Meeting, taking place May 7-11, in Baltimore.
Poster title: “Utilizing Gene Therapy in Duchenne Muscular Dystrophy – Impact of Continuing Medical Education on Participant Knowledge and Behavior”
Session Date/Time: 5/9/2024 12:00PM
Session Title: Thursday Posters: Musculo-Skeletal Diseases
Presentation Room: Exhibit Hall
Past experience in Gene Therapy Education
Our 2020-2021 inaugural Gene Therapy Congress drew almost 2,000 learners and resulted in this publication of our educational outcomes at the 2022 ASGCT Gene Therapy Congress.
Industry-leading approach to outcomes: Respected as industry leader in CME and patient education outcomes reporting. We show outcomes at different times throughout the program each including select participation, demographic, and engagement metrics.
-
- At-a-glance (45 days post-launch)
- Interim (120 days post-launch)
- Final (60 days post-expiration)
About ASGCT
The American Society of Gene and Cell Therapy (ASGCT) is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals in gene and cell therapy. Our mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies.
The ASGCT Patient Education program provides accurate, reliable, and accessible information about gene and cell therapies to patients and the public. ASGCT collaborates with patient advocacy groups to make sure the information is clear and useful, while members of the ASGCT Patient Outreach Committee use their expertise in the field to provide scientific accuracy.
What Makes Our Education Different
Learn more about the PlatformQ Health and ASGCT Partnership
Contact Maria Arnone at marnone@platformq.com